Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review

JUAN ALBERTO RUANO RUIZJUAN ALBERTO RUANO RUIZ2026-01-292026-01-29202310.3389/fimmu.2023.13393372-s2.0-85182861190https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/37347ImmunologyImmunology and AllergyEfficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping reviewreview article